A meta-analysis of published studies found that MS patients have a lower risk of certain digestive system cancers.

High-dose vitamin D as an add-on treatment for MS provides modest but significant benefits to patients, a meta-analysis ...

Columnist Leigh Anne Nelson once chalked up new neurological symptoms to her MS, but she now realizes that assumption could ...

Scientists discovered a genetic marker that predicts before MS therapy whether glatiramer acetate or interferon is likely to ...

People who develop MS begin using healthcare services more frequently up to 15 years before their MS symptoms first appear.

Enrollment is complete for a Phase 2 trial testing Zenas Biopharma's obexelimab in relapsing MS, with results expected later ...

Columnist Desiree Lama has had to find some self-care strategies for managing her MS while also staying atop her work as a ...

Better physical performance is associated with higher cognitive function in people with MS, particularly in those with ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, ...

Quantum signed a manufacturing agreement for the production of Lucid-MS as it prepares for a Phase 2 trial of the ...

Columnist Ben Hofmeister is able to tell when people want the short answer to questions about his health. Too bad most MS answers are long.

Guest writer Donald Kushner, MD, reflects on the similarities between the main character in a classic film and living with MS.